Analysis of antiviral use efficiency criteria in the complex pharmacotherapy of community acquired pneumonia
According to modern view, bacterial pathogens are the leading and most common cause of community-acquired pneumonia (CAP), but at the same time the results of numerous microbiological studies conducted in recent years showed that viruses confidently play the next leading role of CAP causes. Today, a...
Saved in:
Main Authors: | S. O. Soloviov (Author), I. V. Dziublyk (Author), V. V. Trokhymchuk (Author) |
---|---|
Format: | Book |
Published: |
The State Expert Center of the Ministry of Health of Ukraine,
2019-03-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Pharmacoeconomic research of pharmacotherapy schemes of community-acquired pneumonia with the inclusion of antiviral drugs
by: S. O. Soloviov, et al.
Published: (2020) -
Bioinformation analysis of rotavirus vaccine efficiency
by: S. O. Soloviov, et al.
Published: (2019) -
Conceptual foundations of pharmacoeconomic analysis of prevention technologies of chronic viral infections
by: S. O. Soloviov, et al.
Published: (2019) -
Costs of pharmacotherapy in pediatric patients with community-acquired pneumonia: mathematical and statistical analysis
by: I. A. Narkevich, et al.
Published: (2019) -
Modern approaches to pharmacotherapy of Community-Acquired Pneumonia
by: Anna A. Gavrilova, et al.
Published: (2020)